Weather Updates

FDA approves Abbott’s new stent system

Updated: April 15, 2013 7:00AM

North Chicago-based Abbott’s Xience Xpedition stent system received approval from the U.S. Food and Drug Administration and will launch sales immediately in the U.S., the company said Thursday.

The stent system provides “physicians with a next-generation technology with the largest size matrix in the U.S. market,” the company said.

Stents are used to prop open blocked arteries.

The Xience Xpedition stent features a new stent delivery system. Abbott’s Xience drug-eluting stents, including the new Xpedition, are the first and only in the U.S. market proven safe for direct stenting, which doesn’t use another device, such as a balloon dilatation catheter. And that can save time, Abbott said.

“The launch of Xience Xpedition in the United States will advance Abbott’s worldwide market-leading position in drug-eluting stents,” Abbott’s John Capek, executive vice president, medical devices, said in a statement.

© 2014 Sun-Times Media, LLC. All rights reserved. This material may not be copied or distributed without permission. For more information about reprints and permissions, visit To order a reprint of this article, click here.